Original Article
Treatment of Nevus of Ota with the Q-Switched Ruby Laser
N Engl J Med 1994; 331:1745-1750December 29, 1994
- Abstract
Background
Nevus of Ota is a benign bluish or gray-brown lesion of the eye and the surrounding skin that has been reported to occur in about 1 in 200 people in Japan. Prior treatments have either been ineffective or caused scarring. The Q-switched ruby laser can produce very short high-energy pulses and can selectively target cells that contain pigment, such as dermal melanocytes.
Methods
We treated the skin lesions of 114 patients (25 male and 89 female) with nevi of Ota with a Q-switched ruby laser set to deliver pulses of 6 J per square centimeter of body-surface area at a wavelength of 694.3 nm, with a pulse duration of 30 nanoseconds. The interval between treatments ranged from three to four months. Five dermatologists who were not familiar with the patients independently compared a full set of pretreatment and post-treatment photographs of each patient and determined the percentage of pigment lightening of the affected areas using standard criteria.
Results
Of the 35 patients who received four or five treatments, 33 had an excellent response (lightening of 70 percent or more), and 2 had a good response (lightening of 40 to 69 percent). Of the 31 patients who received three treatments, 4 had an excellent response, 26 a good response, and 1 a fair response (lightening of 10 to 39 percent). Of the 25 patients who received two treatments, 2 had an excellent response, 16 a good response, and 7 a fair response. Of the 23 patients who received one treatment, 3 had a good response, 13 a fair response, and 7 no response (lightening of 9 percent or less). No patient had hypertrophic or atrophic scarring; eight patients had postinflammatory hyperpigmentation for up to two months after the first treatment.
Conclusions
Selective photothermolysis with the Q-switched ruby laser is a safe and effective method for lightening nevi of Ota. Multiple treatments increase the response rate.
Media in This Article
Figure 1
A 30-Year-Old Woman with Nevus of Ota before (Panel A) and after (Panel B) Five Laser Treatments.Figure 2
A 28-Year-Old Woman with Nevus of Ota before (Panel A) and after (Panel B) Five Laser Treatments.Article Activity
- Article
Nevus of Ota is typically a bluish or gray-brown lesion of the eye and the surrounding skin innervated by the first and second branches of the trigeminal nerve.1 Histologically, it is a benign dendritic melanocytosis of the papillary and upper reticular dermis. This serious cosmetic problem occurs in 0.6 percent of Japanese,2 but is also seen in Chinese, East Indians, blacks, and whites. Treatments have included surgical removal, skin grafting, dermabrasion, and cryotherapy. Surgical treatment causes scarring, and cryotherapy, although it may be somewhat effective depending on the site of the lesion, is not reliable and may cause atrophy or scarring if overapplied.
Lasers have also been used to treat nevi of Ota in the past,3 but initially without a firm theoretical or experimental basis. Early treatment techniques were ineffective, and complications such as scarring were common. These disappointing results fostered the belief that laser therapy was harmful, despite the availability of a wide variety of techniques. Selective photothermolysis produces specific, heat-mediated injury to pigmented skin cells and other structures by means of brief and selectively absorbed laser pulses.4,5 Melanin, the pigment in melanosomes, is a potential target for selective photothermolysis, because it is the primary light-absorbing compound of cells exposed to laser energy of a certain wavelength.6
Recently, pulses of Q-switched ruby lasers have been shown to interact selectively with the cutaneous pigmentary system.7 In this technique, energy obtained from a deep-red wavelength (694.3 nm) is allowed to build up in the laser, creating powerful high-energy bursts. One of the benefits of the Q-switched ruby laser may be in the selective targeting of cells that contain pigment, such as dermal melanocytes. To evaluate this technique, we treated patients with nevi of Ota with very short pulses of laser energy conforming to the conditions for selective photothermolysis.
Methods
Laser
A Q-switched ruby laser (model LRT-301A/QS, Toshiba, Tokyo, Japan) was used to deliver pulses of 6 J per square centimeter of body-surface area at a wavelength of 694.3 nm; each pulse lasted 30 nanoseconds. The pulses were delivered through an articulated arm (an optical path that permits flexibility in delivery) and a square aperture (measuring 4 by 4 mm) in contact with the skin. The accuracy of the aim of the device was enhanced through the use of a helium-neon laser whose beam was delivered along the same optical path as the treatment beam. The pulse energy was measured with a meter (model DGX, Ophir, Jerusalem, Israel). The energy density of the laser beam was uniform across the aperture. The laser-pulse energy was typically reproducible from pulse to pulse within ±10 percent.
Patients
The study group comprised 114 patients (25 male and 89 female) with nevi of Ota, ranging in age from 8 to 63 years (mean [ ±SD], 30 ±11), who were treated at the Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan, between September 1990 and August 1993. Only patients for whom both pretreatment and post-treatment clinical photographs were available for comparison were studied. One patient was Korean; all the others were Japanese. Approval for the study was obtained from the institutional review board of Teikyo University. After the nature of the procedure was fully explained, written informed consent was obtained from all patients.
Technique
The patients were treated either without anesthesia or with topical anesthesia (5 percent lidocaine hydrochloride ointment). During all treatment sessions, the eyes of the patients and the clinical staff were protected. The treatment intervals ranged from three to four months. In most sessions, the entire affected area was treated at an energy density of 6 J per square centimeter.
Forty patients had punch biopsies (3 or 4 mm in diameter) of temporal lesions after receiving local anesthesia (subcutaneous injection of 1 percent lidocaine with epinephrine). This biopsy site was chosen because it can be easily hidden by hair. All 40 patients had only one biopsy; some were obtained before treatment, some immediately after treatment, and some at various later times. Histopathological examination was by light and electron microscopy.
Analysis
All patients were photographed before treatment and after each treatment session (every three to four months), including the final session of the study period. Whenever possible, photographs were taken with the same camera, magnification, lighting, angle, and film exposure. Five dermatologists who were not familiar with the patients independently compared the full set of images of the treated nevi with the pretreatment images using photographic slides obtained at each session. Before evaluating these images, the dermatologists agreed on a system of grading the lightening of bluish pigment, hypopigmentation, hyperpigmentation, and scarring based on an examination of several prototypical slides. The percentage of lightening of the nevi was determined by comparing them with normal skin. In this grading system, which used increments of 5 percent, a score of 100 percent corresponded to complete clearing, with no detectable differences from normal skin, and a score of 0 percent corresponded to no clearing. The independent ratings of the five dermatologists were averaged to determine the final degree of lightening. Five levels of treatment response were established according to the percentage of pigmentary lightening: excellent in cases with lightening of 70 percent or more, good in cases with lightening of 40 to 69 percent, fair in cases with lightening of 10 to 39 percent, no change in cases with lightening of 9 percent or less, and worse in cases with darkening of the nevi. The side effects of atrophy and scarring were graded as follows: 0 for no scar, 1 for epidermal alteration, 2 for sclerosis, and 3 or more for hypertrophic scarring. Cutaneous depression and post-treatment hyperpigmentation and hypopigmentation were documented as either present or absent.
Results
Clinical Course
A white square appeared immediately after pigmented skin was exposed to the Q-switched ruby laser.7 A wheal-and-flare response was seen around the irradiated sites about five minutes later. This response was pronounced when periorbital areas were treated. The whitening was more intense in pigmented skin than in the surrounding skin. This white color faded within about 20 minutes.
Superficial punctate erosions limited to the pigmented area were seen in some patients immediately after laser treatment. Occasional petechiae, purpura, and rare punctate hemorrhages confined to the pigmented area were seen, especially in the periorbital areas in older patients with fragile blood vessels. Purpura and hemorrhages were not seen in nonpigmented areas. No patients had exudates or gross bleeding.
The wheal-and-flare response lasted for several hours, and erythema was seen for up to 24 hours. Periorbital edema sometimes persisted for two or three days. Vesicles were occasionally seen during the first three days after laser treatment followed by formation of a brown crust over the treated pigmented area during the first two weeks. After desquamation of the crust in three patients with brown macules, the tint of the nevi changed from brownish to bluish. The changes in the color of other lesions, however, were unremarkable. Eight patients had postinflammatory hyperpigmentation for up to two months after the first treatment; however, these patients did not have remarkable postinflammatory hyperpigmentation after the second treatment. Gradual lightening of the lesions was usually evident after two or three laser treatments. No postexposure infections or hypertrophic or atrophic scarring was noted.
Clinical Efficacy
The clinical results of laser treatment are summarized in Table 1Table 1
Results of Treatment with the Q-Switched Ruby Laser in 114 Patients with Nevi of Ota.. The efficacy rate (the percentage of patients with a good or excellent response to treatment) increased with the number of treatments. Among the 23 patients who had only one treatment, 3 had good responses, 13 had fair responses, and 7 had no response. In contrast, all 18 patients who had five treatments had excellent responses. Examples of the responses in three of the patients who had five treatments are shown in Figure 1Figure 1A 30-Year-Old Woman with Nevus of Ota before (Panel A) and after (Panel B) Five Laser Treatments., Figure 2Figure 2A 28-Year-Old Woman with Nevus of Ota before (Panel A) and after (Panel B) Five Laser Treatments., and Figure 3Figure 3
A 24-Year-Old Woman with Nevus of Ota before (Panel A) and after (Panel B) Five Laser Treatments..Histopathological Analysis
Before treatment, elongated, slender, often slightly wavy dendritic cells containing melanin granules were scattered among the collagen bundles in skin-biopsy specimens. Electron microscopy revealed dermal melanocytes that contained numerous melanosomes. Basal lamina and lamina lucida surrounded some melanocytes. An extracellular sheath of varying thickness surrounded dermal melanocytes outside the basal lamina or the plasma membrane of the melanocytes (Figure 4AFigure 4
Electron Micrographs of Pigmented Skin from a 24-Year-Old Man with Nevus of Ota before (Panel A) and Immediately after (Panel B and Panel C) Laser Treatment.).Treatment with the Q-switched ruby laser injured cells containing melanosomes. Immediately after irradiation, keratinocytes with large central vacuoles and peripheral displacement of nuclear and cytoplasmic structures were seen, with rupture of melanosomes in the deeper part of the epidermis, as described previously.7-12 The dermis contained ruptured melanocytes with fine pigment granules in and around them. it was difficult to identify the cell membrane of these melanocytes on light microscopy.
On electron microscopy, the melanocytes were seen as cellular debris juxtaposed with altered melanosomes. Most melanocytes had complete disruption of melanosomes, characterized by irregular contours, enlargement, and marked disorganization of the internal structures (Figure 4B). These morphologic changes are similar to those described previously.7-12 The melanocytes in the papillary dermis were completely disrupted, making it very difficult to recognize the nuclei and cell membranes. Melanocytes in the reticular dermis, however, had less degeneration, with disruption ranging from pyknotic nuclei with clumped chromatin and giant intracytoplasmic vacuoles to internal disruption of nuclei with peripheral condensation of electron-dense chromatin and ruptured membrane-bound intracytoplasmic vacuoles that pushed the nuclei and damaged melanosomes to the periphery. The degenerative changes were less severe in melanocytes in deeper areas of the skin. No alterations were noted in cells without melanosomes or in collagen bundles, even in areas adjacent to those containing damaged melanocytes (Figure 4C).
The depth to which melanocytes were destroyed was measured in six biopsy specimens of temporal skin obtained within one day after laser treatment. Degeneration of melanocytes was seen to a depth of 1.5 mm from the skin surface, which is nearly equivalent to the thickness of the epidermis and the dermis in the temporal area (1.6 mm).
There was a neutrophilic inflammatory response during the first few days after treatment. By day 10, most of the altered melanosomes were within the macrophages. Biopsy specimens obtained from areas of skin with an excellent response to the Q-switched ruby laser had a decreased number of melanocytes. No evidence of fibrosis was seen in any biopsy specimen.
Discussion
Dermal tissue in nevi of Ota contains large amounts of melanin, which provides an excellent target for the laser. Electron-microscopical examination of nevi immediately after exposure showed destruction of dermal melanocytes, but no changes in surrounding tissues. Skin-biopsy specimens obtained after healing showed a completely normal papillary dermis with some nevus cells remaining deep in the dermis. The absence of fibrosis in the specimens is consistent with the absence of clinical scarring in these patients. The Q-switched ruby laser appears to cause selective destruction of pigmented cells, with negligible damage to surrounding tissues.
Histologic examination showed degeneration of melanocytes to a depth of 1.5 mm from the skin surface, which is about the thickness of the temporal epidermis and dermis. This suggests that pigment macules at the temple can be almost completely eliminated with repeated laser treatments.
Prior studies of the Q-switched ruby laser in the treatment of nevi of Ota13-16 included small numbers of patients, and the number and frequency of treatments varied. We followed a large number of patients with nevi of Ota for a relatively long time and used a standard approach to therapy. Lightening of the pigmented areas of nevi was seen in all patients, although it was not apparent immediately after laser treatment.
Most patients who had had only one or two sessions by August 1993 and had had no response or only a fair response to laser treatment wanted further treatments. We continued to treat these patients in the manner described in the study. All these patients had continued lightening of the affected areas, with no side effects (data not shown). No reversion to the original color has been seen up to three years after the last laser treatment.
The energy density we used was lower than that reported by others,13-15 because despite differences in the intensity of the pulse, the threshold exposure for melanosomal injury remains essentially the same as long as the pulse width (the duration of exposure to the laser) is shorter than the estimated thermal relaxation time of melanosomes (the time needed for 50 percent of the incident energy to dissipate from the target in the form of heat).17
The Q-switched ruby laser is also useful in removing tattoos, in particular those with blue-black pigment. Tattoos applied by amateur tattooers respond better than those applied by professional tattooers,18 because the latter contain a variety of metals in addition to organic dyes. Tattoos applied by professionals may be thermally and mechanically more stable than those applied by amateurs, which often contain amorphous carbon or graphite.
When the Q-switched ruby laser was used to treat tattoos applied by amateurs, marked lightening was seen immediately after desquamation of the crusts covering the treated areas.18 The process of lightening such tattoos differs from the process of lightening nevi of Ota, although both involve pigments located in the dermis. Laser pulses are absorbed by melanin in nevi of Ota and by amorphous carbon or graphite in tattoos. Melanin is thermally so stable that it remains in the exposed areas even after laser pulses have destroyed dermal melanocytes. The nevi of Ota lighten only after the melanin within the altered melanosomes has been phagocytosed by macrophages, which are attracted by the inflammatory reaction, and removed to lymph nodes or other sites. In laser-treated patients with nevi of Ota, it is therefore possible that melanin-laden macrophages that have migrated to lymph nodes may remain there and that melanin may gradually accumulate in regional lymph nodes. In most tattoos applied by amateurs, macrophages have already phagocytosed amorphous carbon or graphite, so laser pulses destroy the heat-labile tattoo pigments, as well as the macrophages containing them. Thus, these tattoos may lighten quickly.
In conclusion, selective photothermolysis with the Q-switched ruby laser is a safe and effective method for lightening nevi of Ota. Multiple treatments increase the response rate. We do not know whether the interval between laser treatments or the number of treatments is more important in lightening the pigmentation. The treatment interval may be more important, because clinical improvement was noted six months to one year after the last treatment in some patients (not included in this study) who received only one or two treatments. Moreover, not all of the melanin within the melanosomes damaged by laser irradiation is transported to lymph nodes. Thus, additional treatments may be required.
Supported in part by funds from the Cosmetology Research Foundation (J 90-11) and by a grant from the Ministry of Education, Science, and Culture of Japan (04670649).
We are indebted to Drs. Mayumi Tosa, Atsuko Gotoh, Chikako Matsumura, Hiromi Suenaga, and Chitose Takahashi for their photographic analysis and to the Toshiba Corporation for providing technical assistance and the Q-switched ruby laser.
Source Information
From the Department of Dermatology, Teikyo University School of Medicine, 11-1, Kaga, 2 chome, Itabashi-ku, Tokyo 173, Japan, where reprint requests should be addressed to Dr. Watanabe.
- References
References
1
Mosher DB, Fitzpatrick TB, Ortonne J-P, Hori Y. Disorders of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine: textbook and atlas. 3rd ed. Vol. 1. New York: McGraw-Hill, 1987:854-6.
2
Hidano A ,Kajima H ,Ikeda S ,Mizutani H ,Miyasato H ,Niimura M . Natural history of nevus of Ota. Arch Dermatol 1967;95:187-195
CrossRef | Web of Science | Medline3
Apfelberg DB ,Moser MR ,Lash H ,Rivers J . The argon laser for cutaneous lesions. JAMA 1981;245:2073-2075
CrossRef | Web of Science | Medline4
Anderson RR ,Parrish JA . Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-527
CrossRef | Web of Science | Medline5
Anderson RR ,Parrish JA . Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981;1:263-276
CrossRef | Medline6
Anderson RR ,Parrish JA . The optics of human skin. J Invest Dermatol 1981;77:13-19
CrossRef | Web of Science | Medline7
Polla LL ,Margolis RJ ,Dover JS , et al. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol 1987;89:281-286
CrossRef | Web of Science | Medline8
Dover JS ,Margolis RJ ,Polla LL , et al. Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses -- morphologic and histologic findings. Arch Dermatol 1989;125:43-49
CrossRef | Web of Science | Medline9
Anderson RR ,Margolis RJ ,Watanabe S ,Flotte T ,Hruza GJ ,Dover JS . Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 1989;93:28-32
CrossRef | Web of Science | Medline10
Margolis RJ ,Dover JS ,Polla LL , et al. Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med 1989;9:389-397
CrossRef | Web of Science | Medline11
Hruza GJ ,Dover JS ,Flotte TJ ,Goetschkes M ,Watanabe S ,Anderson RR . Q-switched ruby laser irradiation of normal skin: histologic and ultrastructural findings. Arch Dermatol 1991;127:1799-1805
CrossRef | Web of Science | Medline12
Murphy GF ,Shepard RS ,Paul BS ,Menkes A ,Anderson RR ,Parrish JA . Organelle-specific injury to melanin-containing cells in human skin by pulsed laser irradiation. Lab Invest 1983;49:680-685
Web of Science | Medline13
Goldberg DJ ,Nychay SG . Q-switched ruby laser treatment of nevus of Ota. J Dermatol Surg Oncol 1992;18:817-821
Medline14
Geronemus RG . Q-switched ruby laser therapy of nevus of Ota. Arch Dermatol 1992;128:1618-1622
CrossRef | Web of Science | Medline15
Lowe NJ ,Wieder JM ,Sawcer D ,Burrows P ,Chalet M . Nevus of Ota: treatment with high energy fluences of the Q-switched ruby laser. J Am Acad Dermatol 1993;29:997-1001
CrossRef | Web of Science | Medline16
Taylor CR ,Flotte TJ ,Gange RW ,Anderson RR . Treatment of nevus of Ota by Q-switched ruby laser. J Am Acad Dermatol 1994;30:743-751
CrossRef | Web of Science | Medline17
Watanabe S ,Anderson RR ,Brorson S ,Dalickas G ,Fujimoto JG ,Flotte TJ . Comparative studies of femtosecond to microsecond laser pulses on selective pigmented cell injury in skin. Photochem Photobiol 1991;53:757-762
Web of Science | Medline18
Taylor CR ,Gange RW ,Dover JS , et al. Treatment of tattoos by Q-switched ruby laser: a dose-response study. Arch Dermatol 1990;126:893-899
CrossRef | Web of Science | Medline
- Citing Articles (48)
Citing Articles
1
Ariel Hasson, Cristián P. Navarrete-Dechent, Claudia Nicklas, Néstor Carreño. (2012) Láser Q-Swtiched Nd: YAG 1.064nm para el tratamiento del nevus de Ota: resultados en 22 pacientes y revisión de la literatura. Piel
CrossRef2
JIA LIU, YUAN-PING MA, XIAO-GUANG MA, JOHN Z.S. CHEN, YAN SUN, HONG-HUI XU, XING-HUA GAO, HONG-DUO CHEN, YUAN-HONG LI. (2011) A Retrospective Study of Q-Switched Alexandrite Laser in Treating Nevus of Ota. Dermatologic Surgery 37:10, 1480-1485
CrossRef3
KRISTEL D. POLDER, JENNIFER M. LANDAU, IRENE J. VERGILIS-KALNER, LEONARD H. GOLDBERG, PAUL M. FRIEDMAN, SUZANNE BRUCE. (2011) Laser Eradication of Pigmented Lesions: A Review. Dermatologic Surgery 37:5, 572-595
CrossRef4
Thierry Fusade, Severine Lafaye, Hans-Joachim Laubach. (2011) Nevus of Ota in dark skin-an uncommon but treatable entity. Lasers in Surgery and Medicinen/a-n/a
CrossRef5
Joanne L. Thomas, Tom S. Lister, Sue L. Royston, Philip A. Wright. (2010) Adverse effects following Q-switched ruby laser treatment of pigmented lesions. Journal of Cosmetic and Laser Therapy 12:2, 101-105
CrossRef6
A. V. Anstey. 2010. Disorders of Skin Colour. , 1-59.
CrossRef7
Tohru Kimura. (2009) The Effects of UVA Irradiation on Depigmented Sites in the Skin of the Hairless Dog. Photomedicine and Laser Surgery 27:5, 749-755
CrossRef8
K. Kishi, K. Okabe, R. Ninomiya, E. Konno, N. Hattori, K. Katsube, N. Imanish, H. Nakajima, T. Nakajima. (2009) Early serial Q-switched ruby laser therapy for medium-sized to giant congenital melanocytic naevi. British Journal of Dermatology 161:2, 345-352
CrossRef9
Masakazu Kurita, Harunosuke Kato, Kotaro Yoshimura. (2009) A therapeutic strategy based on histological assessment of hyperpigmented skin lesions in Asians. Journal of Plastic, Reconstructive & Aesthetic Surgery 62:7, 955-963
CrossRef10
Lily Talakoub, Naissan O. Wesley. (2009) Differences in Perceptions of Beauty and Cosmetic Procedures Performed in Ethnic Patients. Seminars in Cutaneous Medicine and Surgery 28:2, 115-129
CrossRef11
Stephanie G.Y. Ho, Henry H.L. Chan. (2009) The Asian Dermatologic Patient. American Journal of Clinical Dermatology 10:3, 153-168
CrossRef12
ANETTA RESZKO, SEAN A. SUKAL, ROY G. GERONEMUS. (2008) Reversal of Laser-Induced Hypopigmentation with a Narrow-Band UV-B Light Source in a Patient with Skin Type VI. Dermatologic Surgery 34:10, 1423-1426
CrossRef13
Shinichi Watanabe. (2008) Basics of laser application to dermatology. Archives of Dermatological Research 300:S1, 21-30
CrossRef14
Akira Momosawa, Masakazu Kurita, Mine Ozaki, Shinpei Miyamoto, Yo Kobayashi, Izumi Ban, Kiyonori Harii. (2008) Combined Therapy Using Q-Switched Ruby Laser and Bleaching Treatment with Tretinoin and Hydroquinone for Periorbital Skin Hyperpigmentation in Asians. Plastic and Reconstructive Surgery 121:1, 282-288
CrossRef15
Ikuko Nagata, Isao Sugimoto, Kazunobu Hashikawa, Hiroto Terashi, Daisuke Sugiyama, Syunichi Kumagai, Shinya Tahara. (2008) Nippon Laser Igakkaishi 29:1, 26-29
CrossRef16
Vishal Madan, Paul J August. (2007) Role of lasers in the treatment of benign pigmented lesions. Expert Review of Dermatology 2:5, 663-670
CrossRef17
Siegrid S. Yu, Shan Pai, Isaac M. Neuhaus, Roy C. Grekin. (2007) Diagnosis and Treatment of Pigmentary Disorders in Asian Skin. Facial Plastic Surgery Clinics of North America 15:3, 367-380
CrossRef18
SEIJI KAWANA, HIROTAKE OCHIAI, RIEKO TACHIHARA. (2007) Objective Evaluation of the Effect of Intense Pulsed Light on Rosacea and Solar Lentigines by Spectrophotometric Analysis of Skin Color. Dermatologic Surgery 33:4, 449-454
CrossRef19
SHINICHI WATANABE, KENJI NAKAI, TAKAMITSU OHNISHI. (2006) Condition Known as “Dark Rings Under the Eyes” in the Japanese Population is a Kind of Dermal Melanocytosis Which can be Successfully Treatedby Q-Switched Ruby Laser. Dermatologic Surgery 32:6, 785-789
CrossRef20
Christina E. Jones, Keyvan Nouri. (2006) Laser treatment for pigmented lesions: a review. Journal of Cosmetic Dermatology 5:1, 9-13
CrossRef21
Shinichi Watanabe. (2006) The Basis of Laser Application to Dermatology. Nippon Laser Igakkaishi 27:4, 315-326
CrossRef22
Harue Suzuki, R. Rox Anderson. (2005) Treatment of melanocytic nevi. Dermatologic Therapy 18:3, 217-226
CrossRef23
Yuichi Teraki, Takeji Nishikawa. (2005) Skin diseases described in Japan 2004. In Japan beschriebene Dermatosen 2004. Journal der Deutschen Dermatologischen Gesellschaft 3:1, 9-25
CrossRef24
Tohru Kimura, Kunio Doi. (2004) Q‐switched ruby laser irradiation on spotty pigmentation in the skin of the hairless dog. Journal of Cosmetic and Laser Therapy 6:2, 61-68
CrossRef25
Bangjin Lee, You Chan Kim, Won Hyoung Kang, Eun-So Lee. (2004) Comparison of Characteristics of Acquired Bilateral Nevus of Ota-like Macules and Nevus of Ota According to Therapeutic Outcome. Journal of Korean Medical Science 19:4, 554
CrossRef26
Akira Momosawa, Kotaro Yoshimura, Gentaro Uchida, Katsujiro Sato, Emiko Aiba, Daisuke Matsumoto, Hisayo Yamaoka, Saori Mihara, Katsuhiko Tsukamoto, Kiyonori Harii, Takao Aoyama, Tatsuji Iga. (2003) Combined Therapy Using Q-Switched Ruby Laser and Bleaching Treatment With Tretinoin and Hydroquinone for Acquired Dermal Melanocytosis. Dermatologic Surgery 29:10, 1001-1007
CrossRef27
Taro Kono, Henry H.L. Chan, Ali Riza Er
en, Yuji Kikuchi, Shoichi Uezono, Susumu Iwasaka, Tsukasa Isago, Motohiro Nozaki. (2003) Use of Q-switched ruby laser in the treatment of nevus of ota in different age groups. Lasers in Surgery and Medicine 32:5, 391-395
CrossRef28
Henry H.L. Chan, Taro Kono. (2003) Nevus of Ota: Clinical Aspects and Management. SKINmed 2:2, 89-98
CrossRef29
Henry H.L. Chan, Lai-kun Lam, David S.Y. Wong, W.I. Wei. (2003) Role of skin cooling in improving patient tolerability of Q-switched Alexandrite (QS Alex) laser in nevus of Ota treatment. Lasers in Surgery and Medicine 32:2, 148-151
CrossRef30
Taro Kono, Ali Rza Erçöçen, Henry H. L. Chan, Yuji Kikuchi, Motohiro Nozaki. (2002) Effectiveness of the Normal-Mode Ruby Laser and the Combined (Normal-Mode Plus Q-Switched) Ruby Laser in the Treatment of Congenital Melanocytic Nevi: A Comparative Study. Annals of Plastic Surgery 49:5, 476-485
CrossRef31
Henry H. Chan, Murad Alam, Taro Kono, Jeffery S. Dover. (2002) Clinical Application of Lasers in Asians. Dermatologic Surgery 28:7, 556-563
CrossRef32
W LOU, R GERONEMUS. (2002) Dermatologic laser surgery*. Seminars in Cutaneous Medicine and Surgery 21:2, 107-128
CrossRef33
Aaron Ying-Ming Lam, David Sau-Yan Wong, Lai-Kun Lam, Wai-Sun Ho, Henry Hin-Lee Chan. (2001) A Retrospective Study on the Efficacy and Complications of Q-Switched Alexandrite Laser in the Treatment of Acquired Bilateral Nevus of Ota-Like Macules. Dermatologic Surgery 27:11, 937-942
CrossRef34
Taro Kono, Motohiro Nozaki, Henry H. Chan, Yoshinori Mikashima. (2001) A retrospective study looking at the long-term complications of Q-switched Ruby laser in the treatment of nevus of Ota. Lasers in Surgery and Medicine 29:2, 156-159
CrossRef35
Gerardo A. Moreno-Arias, Alejandro Camps-Fresneda. (2001) Treatment of nevus of Ota with the Q-switched alexandrite laser. Lasers in Surgery and Medicine 28:5, 451-455
CrossRef36
Murad Alam, Kenneth A. Arndt, Jeffrey S. Dover. (2001) Laser treatment of nevus of Ota. Dermatologic Therapy 14:1, 55-59
CrossRef37
(2001) IMCAS - International Master Course on Ageing Skin. Paris, January 2001. Journal of Cosmetic and Laser Therapy 3:1, 13-49
CrossRef38
Henry H. Chan, Lai-kun Lam, David S.Y. Wong, Ronald S.C. Leung, Shun-yuen Ying, Cham-fai Lai, Wai-sun Ho, John K.H. Chua. (2001) Nevus of Ota: A new classification based on the response to laser treatment. Lasers in Surgery and Medicine 28:3, 267-272
CrossRef39
Tina S. Alster, Jason R. Lupton. (2001) Lasers in Dermatology. American Journal of Clinical Dermatology 2:5, 291-303
CrossRef40
Henry H. Chan, Ronald S. C. Leung, Shun-Yuen Ying, Cham-Fai Lai, Taro Kono, John K. H. Chua, Wai-Sun Ho. (2000) A Retrospective Analysis of Complications in the Treatment of Nevus of Ota with the Q-Switched Alexandrite and Q-Switched Nd:YAG Lasers. Dermatologic Surgery 26:11, 1000-1006
CrossRef41
Henry H. Chan, Shun-Yuen Ying, Wai-Sun Ho, Taro Kono, Walter W. King. (2000) An In Vivo Trial Comparing the Clinical Efficacy and Complications of Q-Switched 755 nm Alexandrite and Q-Switched 1064 nm Nd:YAG Lasers in the Treatment of Nevus of Ota. Dermatologic Surgery 26:10, 919-922
CrossRef42
Niwat Polnikorn, Somsak Tanrattanakorn, David J. Goldberg. (2000) Treatment of Hori's Nevus with the Q-Switched Nd:YAG Laser. Dermatologic Surgery 26:5, 477-480
CrossRef43
S. Ueda, M. Isoda, S. Imayama. (2000) Response of naevus of Ota to Q-switched ruby laser treatment according to lesion colour. British Journal of Dermatology 142:1, 77-83
CrossRef44
B CARPO, J GREVELINK, S GREVELINK. (1999) Laser treatment of pigmented lesions in children. Seminars in Cutaneous Medicine and Surgery 18:3, 233-243
CrossRef45
Henry H.L. Chan, Walter W.K. King, Eric S.Y. Chan, Chun On Mok, Wai Sun Ho, Charlotte Van Krevel, Lau WY. (1999) In vivo trial comparing patients' tolerance of Q-switched Alexandrite (QS Alex) and Q-switched Neodymium:Yttrium-Aluminum-Garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota. Lasers in Surgery and Medicine 24:1, 24-28
CrossRef46
Girish Gupta, Iain R. MacKay, Rona M. MacKie. (1999) Q-switched ruby laser in the treatment of labial melanotic macules. Lasers in Surgery and Medicine 25:3, 219-222
CrossRef47
Ichiro Ono, Tohru Tateshita. (1998) Efficacy of the Ruby Laser in the Treatment of Ota's Nevus Previously Treated Using Other Therapeutic Modalities. Plastic & Reconstructive Surgery 102:7, 2352-2357
CrossRef48
Takashi Nagase, Masanori Takanashi, Hiroko Takada, Kitaro Ohmori. (1997) Extensive vesiculobullous eruption following limited ruby laser treatment for incontinentia pigmenti: A case report. Australasian Journal of Dermatology 38:3, 155-157
CrossRef
